Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asia More “Enlightened” Regulatory Environment – Pharmaxis CEO

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - Sydney-based Pharmaxis will submit its marketing authorization application for chronic lung condition drug Bronchitol to Australia's Therapeutic Good Administration in the third quarter of 2008

You may also be interested in...



PharmAsia News Australia/New Zealand Roundup: Medicines Australia, PHARMAC, Helicon, Pharmaxis

Medicines Australia Critical Of Labor Government's First Budget

PharmAsia News Australia/New Zealand Roundup: Medicines Australia, PHARMAC, Helicon, Pharmaxis

Medicines Australia Critical Of Labor Government's First Budget

Aussie Pharma Pharmaxis Submits Bronchitol Application to China’s State FDA

PERTH, Australia - Sydney-based Pharmaxis submitted a clinical trial application to China's State FDA for chronic lung condition drug Bronchitol (mannitol) for treatment of bronchiectasis, the company announced March 7

UsernamePublicRestriction

Register

MT125711

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel